You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-PD-1 antibodies

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NON-breast HER2+ Malignancies Trial in Worldwide (NJH395)

Completed
  • NON-breast HER2+ Malignancies
  • Houston, Texas
  • +3 more
Jan 21, 2022

Mesothelioma Trial in France (Nivolumab, Nivolumab + Ipilimumab)

Completed
  • Mesothelioma
  • Angers, France
  • +21 more
Feb 9, 2021

Advanced Head, Neck and Chest Cancer Trial in Beijing (AK105, Anlotinib)

Recruiting
  • Advanced Head, Neck and Chest Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences and Peking
Jun 21, 2020

Hiv Trial (behavioral therapy and education)

Not yet recruiting
  • Hiv
  • behavioral therapy and education
  • (no location specified)
Jun 28, 2023

Influenza Trial in Ecatepec de Morelos, Cuernavaca, Mexico City (Multi-dose Quadrivalent Influenza Vaccine, Single-dose

Completed
  • Influenza
  • Multi-dose Quadrivalent Influenza Vaccine
  • Single-dose Quadrivalent Influenza Vaccine
  • Ecatepec de Morelos, Estado De Mexico, Mexico
  • +2 more
Apr 21, 2022

Delirium in Old Age, Anaesthetic Trial in Jinan (propofol infusion, sevoflurane inhalation)

Recruiting
  • Delirium in Old Age
  • Anaesthetic
  • propofol infusion
  • sevoflurane inhalation
  • Jinan, Shandong, China
  • +1 more
May 28, 2022

Oxidative Stress, Inflammation, Body Weight Trial in Ioannina (Hydroxytyrosol/Essential oils)

Completed
  • Oxidative Stress
  • +3 more
  • Hydroxytyrosol/Essential oils
  • Ioannina, Epirus, Greece
    University of Ioannina
Jan 9, 2023

Low-Grade Squamous Intraepithelial Lesions Trial in Tuzla, Zagreb (DL-alpha lipoic acid, (rice starch))

Completed
  • Low-Grade Squamous Intraepithelial Lesions
  • DL-alpha lipoic acid
  • placebo (rice starch)
  • Tuzla, Bosnia and Herzegovina
  • +1 more
Jul 31, 2022

Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Cataract
  • Walnut Creek, California
    Bay Area Retina Associates
Mar 1, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
May 28, 2022

Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels

Recruiting
  • Oropharynx Squamous Cell Carcinoma
  • +3 more
  • IO102
  • IO103
  • Brussels, Belgium
    Cliniques Universitaires Saint-Luc
May 6, 2022

Opportunistic Autoimmune Diseases Trial in Strasbourg (Biological collection)

Recruiting
  • Opportunistic Autoimmune Diseases
  • Biological collection
  • Strasbourg, Alsace, France
    Hopitaux universitaires de strasbourg
Aug 17, 2022

Hematologic Malignancies Trial in China, United States (GFH009)

Recruiting
  • Hematologic Malignancies
  • New Orleans, Louisiana
  • +16 more
Aug 2, 2022

Human Papilloma Virus, Cervical Cancer, Oropharyngeal Cancer Trial run by the NCI (M7824)

Active, not recruiting
Has Results
  • Human Papilloma Virus
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 28, 2022

Physical Activity, Blood Pressure Trial in Uberlândia (Hypertensive group, Normotensive group)

Completed
  • Physical Activity
  • Blood Pressure
  • Hypertensive group
  • Normotensive group
  • Uberlândia, Minas Gerais, Brazil
    Jaqueline Pontes Batista
Mar 7, 2022

Retinal Revascularization and Clinical Indicators of Neovascular

Recruiting
  • Wet Macular Degeneration
  • Ophthalmic Drugs
  • Arendal, Agder, Norway
    Sorlandet Hospital HF
Mar 3, 2022

NSCLC Trial in Worldwide (Durvalumab, Placebo, Carboplatin/Paclitaxel)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Phoenix, Arizona
  • +233 more
Nov 18, 2022

Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

Not yet recruiting
  • Healthy
  • Camlipixant + Rifampin
  • Camlipixant + Rabeprazole
  • Québec, Quebec, Canada
    Syneos Health
Jun 2, 2023

LGMD2I Trial in Baltimore (PF 06252616)

Completed
Has Results
  • LGMD2I
  • PF 06252616
  • Baltimore, Maryland
    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Sep 23, 2020

Major Abdominal Surgery Trial in Alexandria (Dexmedetomidine, 0.9% sodium chloride)

Recruiting
  • Major Abdominal Surgery
  • Alexandria, Egypt
    Rehab Abd Elraof Abd Elaziz
May 29, 2022

Coronary Artery Disease Trial (Coronary artery bypass grafting based on conventional coronary angiography, Coronary artery

Not yet recruiting
  • Coronary Artery Disease
  • Coronary artery bypass grafting based on conventional coronary angiography
  • Coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.
  • (no location specified)
Sep 9, 2023

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Recruiting
  • Metastatic Renal Cell Carcinoma
  • No intervention required
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Parkinson Disease Trial in Milan (Tangotherapy, Physical activity)

Recruiting
  • Parkinson Disease
  • Tangotherapy
  • Physical activity
  • Milan, Lombardia, Italy
    Istituto Auxologico Italiano IRCCS
Jun 6, 2023

ST Elevation Myocardial Infarction Trial in Worldwide (MEDI6012, Placebo)

Completed
Has Results
  • ST Elevation Myocardial Infarction
  • MEDI6012
  • Placebo
  • Belo Horizonte, Brazil
  • +36 more
Jan 13, 2022

MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)

Enrolling by invitation
  • Major Depressive Disorder
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 12, 2022